Spotting Winners: Sarepta Therapeutics (NASDAQ:SRPT) And Therapeutics Stocks In Q4
As the Q4 earnings season wraps, let’s dig into this quarter’s best and worst performers in the therapeutics industry, including Sarepta Therapeutics (NASDAQ:SRPT) and its peers. ...
Branded Pharmaceuticals Stocks Q4 In Review: Bristol-Myers Squibb (NYSE:BMY) Vs Peers
Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same sector. Today we are looking at Bristol-Myers Squibb (NYS...
Winners And Losers Of Q4: Akamai (NASDAQ:AKAM) Vs The Rest Of The Content Delivery Stocks
As the Q4 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the content delivery industry, including Akamai (NASDAQ:AKAM) and i...
